Hongliang Wang Selected Research

Enzymes

3/2024	GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation.
5/2023	A new 68Ga-labeled ornithine derivative for PET imaging of ornithine metabolism in tumors.
1/2023	Spike protein mediated membrane fusion during SARS-CoV-2 infection.
1/2022	External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
1/2022	High PLA2 level is correlated with glioblastoma progression via regulating DNA replication.
3/2021	Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging.
3/2015	Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongliang Wang Research Topics

Disease

44	Neoplasms (Cancer) 05/2024 - 02/2007
13	Infections 02/2024 - 02/2012
12	Glioma (Gliomas) 11/2022 - 10/2013
11	Inflammation (Inflammations) 04/2024 - 11/2012
10	Sepsis (Septicemia) 12/2023 - 10/2016
8	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2021
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2003
7	COVID-19 01/2023 - 12/2020
7	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2015
6	Acute Lung Injury 06/2021 - 04/2008
5	Virus Diseases (Viral Diseases) 01/2024 - 02/2019
5	Mastitis 01/2022 - 02/2014
5	Hepatocellular Carcinoma (Hepatoma) 04/2017 - 08/2013
4	Body Weight (Weight, Body) 12/2023 - 01/2020
4	Critical Illness (Critically Ill) 01/2023 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 10/2015
4	Fibrosarcoma 04/2017 - 08/2014
4	Osteosarcoma (Osteogenic Sarcoma) 10/2016 - 01/2015
3	Liver Diseases (Liver Disease) 12/2023 - 06/2017
3	Thrombosis (Thrombus) 12/2023 - 10/2020
3	Carcinogenesis 05/2023 - 12/2013
3	Osteoporosis 02/2023 - 08/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 04/2022
3	Human Influenza (Influenza) 09/2021 - 02/2019
3	Pneumonia (Pneumonitis) 04/2021 - 01/2019
2	Atherosclerosis 04/2024 - 05/2017
2	Myocardial Infarction 04/2024 - 01/2019
2	Infarction (Infarctions) 04/2024 - 10/2021
2	Enterovirus Infections 02/2024 - 01/2023
2	Necrosis 12/2023 - 04/2017
2	Hemorrhage 12/2023 - 01/2020
2	Pain (Aches) 12/2023 - 09/2023
2	Venous Thromboembolism 12/2023 - 10/2020
2	Wounds and Injuries (Trauma) 12/2023 - 01/2020
2	Hypoxia (Hypoxemia) 11/2023 - 10/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 02/2021
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2023
2	Obesity 01/2023 - 06/2022
2	Hypertension (High Blood Pressure) 01/2023 - 04/2021
2	Birth Weight (Birth Weights) 08/2022 - 05/2020
2	Heart Failure 01/2022 - 01/2020
2	Fatty Liver 01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2008
8	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 11/2012
8	Small Interfering RNA (siRNA)IBA 10/2018 - 02/2007
7	EnzymesIBA 03/2024 - 03/2015
7	Amino Acids FDA Link 05/2023 - 02/2011
7	Long Noncoding RNAIBA 01/2023 - 04/2019
6	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2018
6	MicroRNAs (MicroRNA)IBA 10/2019 - 02/2014
5	Antiviral Agents (Antivirals)IBA 01/2024 - 02/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 02/2007
4	Lactic Acid (Lactate)FDA LinkGeneric 08/2023 - 03/2019
4	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
4	HDL CholesterolIBA 01/2023 - 05/2020
4	CholesterolIBA 01/2023 - 05/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2022 - 10/2018
4	RNA (Ribonucleic Acid)IBA 09/2021 - 11/2017
4	Liposomes (Liposome)IBA 09/2020 - 06/2016
4	AcidsIBA 01/2016 - 04/2008
3	PolyaminesIBA 04/2024 - 03/2021
3	CalciumIBA 02/2024 - 01/2021
3	Peptides (Polypeptides)IBA 01/2024 - 01/2015
3	Oxygen (Dioxygen)IBA 08/2023 - 09/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 06/2016
3	Indicators and Reagents (Reagents)IBA 05/2023 - 02/2012
3	AlkaloidsIBA 01/2023 - 04/2022
3	Alanine Transaminase (SGPT)IBA 01/2023 - 06/2017
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 12/2015
3	Vitamin D FDA LinkGeneric 01/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 07/2017 - 02/2007
3	TurpentineIBA 04/2015 - 11/2012
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2024 - 05/2023
2	salicylhydroxamic acid (SHAM)IBA 04/2024 - 01/2019
2	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 02/2024 - 05/2014
2	AcetyltransferasesIBA 01/2024 - 01/2022
2	Dexmedetomidine FDA Link 12/2023 - 06/2017
2	CreatinineIBA 12/2023 - 05/2023
2	AnticoagulantsIBA 12/2023 - 04/2021
2	IonsIBA 11/2023 - 04/2017
2	Toll-Like Receptor 4IBA 10/2023 - 04/2008
2	BilirubinIBA 08/2023 - 05/2023
2	C-Reactive ProteinIBA 05/2023 - 09/2021
2	OrnithineIBA 05/2023 - 03/2021
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 05/2023 - 03/2021
2	Silicic AcidIBA 02/2023 - 01/2021
2	XuebijingIBA 01/2023 - 01/2019
2	AntibodiesIBA 12/2022 - 12/2021
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2022 - 01/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2022 - 04/2008
2	LipidsIBA 06/2022 - 01/2022
2	FlavonoidsIBA 06/2022 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 06/2022 - 01/2011
2	LipopolysaccharidesIBA 01/2022 - 01/2019

Therapy/Procedure

11	Therapeutics 04/2024 - 02/2012
7	Drug Therapy (Chemotherapy) 07/2021 - 08/2013
4	Transplantation 06/2022 - 03/2011
2	Length of Stay 02/2024 - 09/2021
2	Critical Care (Surgical Intensive Care) 01/2023 - 01/2021
2	Oral Administration 01/2023 - 06/2022